M. Deebajah*

发表

Barriers to obtaining prostate multi‐parametric magnetic resonance imaging in African‐American men on active surveillance for prostate cancer

M. Menon, J. Peabody, C. Rogers, 2019, Cancer medicine.

Protocol for phase I study of pembrolizumab in combination with Bacillus Calmette-Guérin for patients with high-risk non-muscle invasive bladder cancer

A. Sood, Krishna Rao, S. Alanee, 2019, BMJ Open.

Combination of pembrolizumab and BCG treatment after endoscopic ablation of high-risk superficial upper urinary tract urothelial carcinoma in patients not candidates for radical nephroureterectomy: protocol for phase-II study

A. Sood, S. Alanee, M. Deebajah*, 2019, BMJ Open.

Post prostatectomy Pathologic Findings of Patients with Clinically Significant Prostate Cancer and no Significant PI-RADS Lesions on Preoperative Magnetic Resonance Imaging.

M. Menon, J. Peabody, S. Williamson, 2020, Urology.

Utilizing lesion diameter and prostate specific antigen density to decide on magnetic resonance imaging guided confirmatory biopsy of prostate imaging reporting and data system score three lesions in African American prostate cancer patients managed with active surveillance

M. Menon, J. Peabody, S. Alanee, 2022, International Urology and Nephrology.

The effect of multiplicity of PI-RADS 3 lesions on cancer detection rate of confirmatory targeted biopsy in patients diagnosed with prostate cancer and managed with active surveillance.

M. Menon, J. Peabody, S. Williamson, 2020, Urologic oncology.

Effect of Lesion Location on Prostate Cancer Detection Rate with Magnetic Resonance Imaging Targeted Biopsy in African Americans

M. Menon, J. Peabody, S. Alanee, 2019, The Journal of urology.

Prognostic significance of histomorphologic features of lymph node metastases in prostate cancer patients treated with radical prostatectomy: A single center study.

S. Williamson, M. Alhamar, S. Alanee, 2021, Urologic oncology.

Prostate volume measured by magnetic resonance imaging is not a predictor of lower urinary tract symptoms

S. Alanee, M. Pantelic, A. Dabaja, 2019, Journal of family medicine and primary care.

Phase I trial of intravesical Bacillus Calmette–Guérin combined with intravenous pembrolizumab in recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous Bacillus Calmette–Guérin treatment

J. Peabody, Krishna Rao, K. McVary, 2021, World Journal of Urology.

Systematic biopsy does not contribute to disease upgrading in patients undergoing targeted biopsy for PI-RADS 5 lesions identified on magnetic resonance imaging in the course of active surveillance for prostate cancer.

M. Menon, J. Peabody, S. Williamson, 2019, Urology.

Machine learning-based prediction of upgrading on magnetic resonance imaging targeted biopsy in patients eligible for active surveillance.

M. Menon, J. Peabody, A. Alkhateeb, 2022, Urologic oncology.

Using adaptive genetic algorithms combined with high sensitivity single cell-based technology to detect bladder cancer in urine and provide a potential noninvasive marker for response to anti-PD1 immunotherapy.

Pin-i Chen, S. Alanee, B. Patterson, 2020, Urologic oncology.

Endocrine, Sexual Function, and Infertility Side Effects of Immune Checkpoint Inhibitor Therapy for Genitourinary Cancers

A. Sood, S. Alanee, F. Abdollah, 2018, Current Urology Reports.

Prostate cancer with comedonecrosis is frequently, but not exclusively, intraductal carcinoma: a need for reappraisal of grading criteria

N. Palanisamy, S. Williamson, S. Alanee, 2019, Histopathology.

Podocytopathies related to either COVID-19 infection or its vaccination, our experience and literature review

N. Blatt, H. Kanaan, Wei Li, 2023, Ultrastructural pathology.